In response to Fogarty et al. and why adjuvant whole brain radiotherapy is not recommended routinely

The routine use of adjuvant whole brain radiotherapy (AWBRT) after surgery or stereotactic radiosurgery is now discouraged by a number of international expert panels. Three decades of randomised studies have shown that, although AWBRT improves radiological measures of intracranial disease control, the clinical benefit is unclear and it is also associated with inferior quality of life and neurocognitive function. | In response to Fogarty et al. and why adjuvant whole brain radiotherapy is not recommended routinely

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN